Literature DB >> 16406714

Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6.

Chang-Hee Suh1, Hye-Young Chun, Young-Min Ye, Hae-Sim Park.   

Abstract

C-reactive protein (CRP) response is abnormal to a non-infectious inflammation in systemic lupus erythematosus (SLE). We evaluated the role of cytokines in this CRP unresponsiveness. The sera of 138 SLE patients and 71 rheumatoid arthritis patients were collected prospectively. SLE with infection had higher WBC count, ESR, CRP and C4 levels than those without infection. IL-6, IL-10 and IFN-gamma levels were higher in SLE with infection than SLE without infection. In SLE with infection, the CRP was correlated with the IL-6 (r = 0.77, P < 0.001) but not correlated with IL-10 and IFN-gamma. These data suggest that IL-6 may have a role in the unresponsiveness of CRP to a non-infectious inflammation of SLE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406714     DOI: 10.1016/j.clim.2005.11.006

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

1.  Usefulness of neutrophil-to-lymphocyte ratio as a biomarker for diagnosing infections in patients with systemic lupus erythematosus.

Authors:  Hyoun-Ah Kim; Ju-Yang Jung; Chang-Hee Suh
Journal:  Clin Rheumatol       Date:  2017-08-24       Impact factor: 2.980

2.  Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort.

Authors:  S P Ardoin; L E Schanberg; C Sandborg; E Yow; H X Barnhart; K l Mieszkalski; N T Ilowite; E von Scheven; A Eberhard; D M Levy; Y Kimura; E Silverman; S L Bowyer; L Punaro; N G Singer; D D Sherry; D McCurdy; M Klein-Gitelman; C Wallace; R Silver; L Wagner-Weiner; G C Higgins; H I Brunner; L K Jung; L Imundo; J B Soep; A M Reed
Journal:  Lupus       Date:  2010-10       Impact factor: 2.911

3.  The role of MBL, PCT, CRP, neutrophil-lymphocyte ratio, and platelet lymphocyte ratio in differentiating infections from flares in lupus.

Authors:  Balaji Musunuri; Rina Tripathy; Sunali Padhi; Aditya K Panda; Bidyut K Das
Journal:  Clin Rheumatol       Date:  2022-07-14       Impact factor: 3.650

4.  Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage.

Authors:  Ana M Bertoli; Luis M Vilá; John D Reveille; Graciela S Alarcón
Journal:  J Rheumatol       Date:  2008-11-01       Impact factor: 4.666

Review 5.  Infection in systemic lupus erythematosus, similarities, and differences with lupus flare.

Authors:  Ju-Yang Jung; Chang-Hee Suh
Journal:  Korean J Intern Med       Date:  2017-04-28       Impact factor: 2.884

6.  The relationship between anti-C-reactive protein and disease activity in patients with systemic lupus erythematosus.

Authors:  Chang-Nam Son; Tae-Han Lee; Ji-Hye Bang; Hye-Jin Jeong; Jin-Nyeong Chae; Won-Mok Lee; Ji-Min Kim; Sang-Hyon Kim
Journal:  Korean J Intern Med       Date:  2017-03-31       Impact factor: 2.884

7.  Thromboangiitis obliterans episode: autoimmune flare-up or reinfection?

Authors:  Mehran Mohareri; Ali Mirhosseini; Saeedeh Mehraban; Bahare Fazeli
Journal:  Vasc Health Risk Manag       Date:  2018-09-28

8.  APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid.

Authors:  Miles Berger; Mary Cooter; Alexander S Roesler; Stacey Chung; John Park; Jennifer L Modliszewski; Keith W VanDusen; J Will Thompson; Arthur Moseley; Michael J Devinney; Shayan Smani; Ashley Hall; Victor Cai; Jeffrey N Browndyke; Michael W Lutz; David L Corcoran
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 9.  Tocilizumab therapy for persistent high-grade fever in systemic lupus erythematosus: two cases and a literature review.

Authors:  Ma Chaoyi; Bikash Shrestha; Li Hui; Ding Qiujin; Fu Ping
Journal:  J Int Med Res       Date:  2022-03       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.